-+ 0.00%
-+ 0.00%
-+ 0.00%

Lunai Bioworks acquires Clemann Group BBB delivery technology and CNS Alzheimer’s assets; deal totals $20 million at $1.50 conversion price

Reuters·03/26/2026 12:51:22

Please log in to view news